Go Back To Menu
Close
- Mailing Form
-
Medical Report*
-
Go Back To Menu
Ovarian cancer mainly occurs in middle-aged and elderly women, especially those over 50 years old. The disease progresses insidiously, with no obvious early symptoms. Missing the treatment window often leads to late-stage detection, significantly increasing treatment difficulty and risk. Active and effective treatment strategies are crucial for prolonging survival and improving quality of life.
As an emerging therapy, immune reconstruction cell therapy enhances the patient’s immune system to recognize and kill tumor cells, showing promising therapeutic potential. Its advantages include:
① Strong targeting ability, reducing damage to normal cells;
② Supporting traditional treatments and enhancing efficacy;
③ Long-term regulation of the immune environment to reduce recurrence risk. Combined with chemotherapy and surgery, this therapy has become a focus of multi-center research.
In actual treatment, since tumor patients undergoing surgery, radiotherapy, and chemotherapy often face impaired immune function, increased infection risk, and slow recovery, it is necessary to scientifically formulate phased immune reconstruction plans for different cycles to better support treatment, improve tolerance, and enhance survival quality.
● Short-term Plan: Rapidly enhance immunity through immune cell reinfusion, boosting the effectiveness of anti-cancer treatment.
● Mid-term Plan: Reduce side effects of traditional treatments, promote physical recovery, and complete standardized treatment courses.
● Long-term Plan: Improve overall immunity through immune cell reconstruction, gut immune reconstruction, elemental immune reconstruction, and immune nutrition reconstruction, thereby enhancing quality of life and extending survival.
1. Surgical Treatment
Surgery is the fundamental treatment for ovarian cancer, aiming to maximize tumor removal. Modern minimally invasive techniques, such as laparoscopic surgery, cause less trauma, allow faster recovery, and are suitable for early patients and as postoperative adjuvant treatment. For advanced patients, cytoreductive surgery remains an important measure to control disease.
2. Chemotherapy
Chemotherapy is a conventional treatment method, mainly using platinum- and taxane-based drugs. Adjuvant chemotherapy reduces the risk of postoperative recurrence and improves cure rates. New chemotherapy regimens combined with targeted drugs further improve efficacy and tolerance.
3. Targeted Therapy
Targeted therapy focuses on specific molecular targets of tumor cells, such as PARP inhibitors, providing personalized treatment options for some patients. Targeted drugs effectively inhibit tumor cell proliferation and metastasis, slowing disease progression.
4. Radiotherapy and Other Treatments
Although radiotherapy is rarely used in ovarian cancer, it provides supportive efficacy for some local recurrence or metastatic lesions. Hormonal therapy and other approaches are also applied in specific cases.
5. Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
During surgery, an intraperitoneal catheter is placed, and postoperative circulation of chemotherapy drugs heated to 42–43°C is performed. This approach targets microscopic residual lesions after cytoreductive surgery, enhancing penetration while keeping complications controllable.
6. Intra-arterial Infusion Chemotherapy
A catheter is inserted from the femoral artery to the ovarian artery to deliver high-concentration chemotherapy drugs (such as paclitaxel). This method is used for advanced patients ineligible for surgery, achieving local drug concentrations over 10 times higher than systemic levels, shrinking tumors to enable surgery, and synergizing with intravenous chemotherapy.
Ovarian cancer treatment requires multidisciplinary comprehensive management, with immune reconstruction cell therapy as an important innovation. Experts at United Life International Medical Center emphasize that choosing personalized plans and integrating minimally invasive and targeted therapies can significantly improve patient survival and quality of life.
